<DOC>
	<DOC>NCT02307175</DOC>
	<brief_summary>Prospective, open label single site study to demonstrate the safety and efficacy of Tc-99m pertechnetate produced by high energy cyclotron at CHUS.</brief_summary>
	<brief_title>A Study of 99m Tc Pertechnetate Produced in High Energy Cyclotron in Patients With Thyroid Scan Indication</brief_title>
	<detailed_description>The proposed clinical trial will be a prospective, case-controlled Phase I, open label, single site study. The first 10 consecutively enrolled patients will receive CYCLOTEC standard procedure thyroid imagery and an additional whole-body scans, and 20 subsequent case-matched controls, will receive GPERT and will also have additionnal whole body scan.</detailed_description>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Hypothyroidism</mesh_term>
	<mesh_term>Congenital Hypothyroidism</mesh_term>
	<mesh_term>Sodium Pertechnetate Tc 99m</mesh_term>
	<criteria>Prescribed thyroid scan Provided written informed consent prior to participation Biochemical parameters within 5 times of the normal limits for age WBC count &gt; 3.0/μL ANC count 1.5/μL Platelets &gt; 75,000/μL Haemoglobin &gt; 10 g/dL Karnofsky Performance Scale score &gt; 50 Nursing or pregnant females Biochemical parameters as measured outside 5 times the normal limits for age within 14 days of the scan WBC &lt; 3.0/μL ANC &lt; 1.5/μL Platelets &lt; 75,000/μL Haemoglobin &lt; 10 g/dL Unable and unwilling to follow instructions and comply with the protocol Unable or unwilling to provide written informed consent prior to participation in the study Karnofsky Performance Scale score &lt; 50</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>